Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes
10:00am, Friday, 26'th Apr 2024
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand
09:41am, Friday, 26'th Apr 2024
ResMed's (RMD) fiscal 2024 third-quarter performance reflects another strong period of execution across the entire business, resulting in impressive top and bottom-line growth.
ResMed Stock Soars After Strong Earnings. Wall Street Thinks It Can Do Even Better.
08:33am, Friday, 26'th Apr 2024
The medical devices company beat expectations for its fiscal third quarter.
ResMed Inc. (RMD) Q3 2024 Earnings Call Transcript
09:38pm, Thursday, 25'th Apr 2024
ResMed Inc. (NYSE:RMD ) Q3 2024 Earnings Conference Call April 25, 2024 4:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Mick Farrell - Chief Executive
Compared to Estimates, ResMed (RMD) Q3 Earnings: A Look at Key Metrics
07:31pm, Thursday, 25'th Apr 2024
While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to
ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
06:26pm, Thursday, 25'th Apr 2024
ResMed (RMD) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $1.68 per share a year ago.
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices
06:15pm, Thursday, 25'th Apr 2024
ResMed beat Wall Street estimates for quarterly profit on Wednesday due to strong demand for its sleep apnea devices, sending shares 9% higher in extended trading.
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
04:05pm, Thursday, 25'th Apr 2024
Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
03:01pm, Wednesday, 24'th Apr 2024
Here is a sneak peek into how the three major MedTech stocks, LH, EW and RMD, are expected to fare in their quarterly results slated to be released tomorrow.
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:08am, Thursday, 18'th Apr 2024
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
06:51pm, Wednesday, 17'th Apr 2024
One of the pharmaceutical giant's hotter medications tested well for a new indication. It has already attracted much attention for the molecule being studied, as it's used in two FDA-approved treatmen
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
04:05pm, Thursday, 04'th Apr 2024
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on Thursday,
5 Medical Product Stocks to Buy Amid Industry Challenges
09:37am, Tuesday, 02'nd Apr 2024
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, RMD, ZBH, PODD and LNTH are well-poi
Here's Why Investors Should Buy ResMed (RMD) Stock Now
01:46pm, Monday, 01'st Apr 2024
Investors are optimistic about ResMed (RMD) led by the strong uptake of the myAir app with Air 11 systems.
The 7 Best Stocks to Buy With Your Required Minimum Distribution (RMD)
04:05pm, Sunday, 31'st Mar 2024
Once you reach the age of 73, there's no getting around Required Minimum Distributions (RMDs). Yet while there's no getting around making this compulsory withdrawal from your 401(k) or IRA, consider i
